Results 61 to 70 of about 14,643 (342)
Focal Spot, Spring/Summer 1985 [PDF]
https://digitalcommons.wustl.edu/focal_spot_archives/1040/thumbnail ...
core +1 more source
De novo urological neoplasms in kidney transplant patients: Experience in 1751 patients
Immunosuppressive treatment promotes development of neoplasms in kidney transplant patients. Cancer prevalence in these patients is 4 to 5 times higher as compared to the general population. Tumors are also known to behave more aggressively in transplant patients.To perform a descriptive analysis of de novo urological tumors in kidney transplant ...
A. Budía Alba+5 more
openaire +4 more sources
CTHRC1 promotes bone metastasis in prostate cancer
What's New? The mechanisms driving bone metastasis in prostate cancer are still unclear, and predicting markers have not yet been identified. Based on the biological characterization of prostate cancer cell lines and integrated data analysis of clinical samples, the authors identified CTHRC1 as a candidate gene regulating prostate cancer bone ...
Yuichiro Sawada+18 more
wiley +1 more source
Background: Artificial intelligence (AI) is changing our life, including the medical field. Repeated machine learning using big data made various fields more predictable and accurate.
Taeyoung Park+8 more
doaj
Urinary Bladder Cancer in Yemen
Objectives: The aims of this study are to highlight the clinicopathological features of urinary bladder cancer in Yemen, and to describe the histological grading of urothelial neoplasms according to the World Health Organization and International Society
Abdullah Saleh Al-Samawi+1 more
doaj +1 more source
The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers [PDF]
Objective: To evaluate the additive value of the prostate cancer gene 3 (PCA3) urine test to serum prostate-specific antigen (PSA) in prostate cancer (PC) screening among breast cancer, early-onset gene (BRCA) mutation carriers.
Aaronson, N.K. (Neil)+38 more
core +1 more source
Patient‐derived xenograft models in pan‐cancer: From bench to clinic
Abstract Patient‐derived xenograft (PDX) models provide a robust preclinical platform that preserves the genetic and phenotypic heterogeneity of patient tumors while mirroring their tumor genetic characteristics, which retain malignant cells and the tumor pathological structure, making them valuable for studying tumor progression and developing ...
Jiatong Li+5 more
wiley +1 more source
A case of primary renal oncocytic tumor: Chromophobe renal cell carcinoma or oncocytoma?
Introduction “Other oncocytic renal tumors of the kidney” is a new category constituted by 2022 WHO classification and different in the point of morphology and immunohistochemistory from typical oncocytic/eosinophilic renal tumors including chromophobe ...
Kenta Matsui+5 more
doaj +1 more source
Malignant Psoas abscess or pseudomyxoma extraperitonei [PDF]
Primary adenocarcinoma of appendix is an uncommon gastrointestinal malignancy. Similarly, Psoas abscess is an entity, which sometimes requires extensive work-up to reach a diagnosis.
Ejaz, Kiran+2 more
core +1 more source
Simultaneous nephrectomy and coronary artery bypass grafting through extended sternotomy [PDF]
BACKGROUND: The advances in surgical techniques, resuscitation and anesthesiology support over the last years have allowed simultaneous thoracic and abdominal operations to be made for cancer and concomitant severe heart vessel disease relieving the ...
Algimantas Budrikis+3 more
core +1 more source